Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Current Molecular Medicine|June 25, 2005
Telomerase therapeutics for degenerative diseasesCalvin B HarleyClinical Ophthalmology (Auckland, N.Z.)|February 13, 2016
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot studyCoad Thomas Dow, Calvin B HarleyRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2010
Imetelstat (GRN163L)--telomerase-based cancer therapyAlexander Röth, Calvin B Harley, Gabriela M BaerlocherRejuvenation Research|July 2, 2013
A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular responseCalvin B Harley, Weimin Liu, Peter L Flom, et al.Journal of Theoretical Biology|November 5, 2002
Cancer cell dynamics in presence of telomerase inhibitors: analysis of in vitro dataIgor A Sidorov, Ken S Hirsch, Calvin B Harley, et al.Mathematical Biosciences|November 26, 2002
Cancer treatment by telomerase inhibitors: predictions by a kinetic modelIgor A Sidorov, Ken S Hirsch, Calvin B Harley, et al.Rejuvenation Research|March 8, 2016
A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled StudyLaura Salvador, Gunasekaran Singaravelu, Calvin B Harley, et al.Blood|March 29, 2003
Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantationRichard C Allsopp, Gregg B Morin, Ronald DePinho, et al.Pageof 3